Tuesday, September 12, 2017
Opioid crisis seems to drive Medicare and insurance companies to demand more doctor visits to scrutinize all prescription refills
I got a text late last night that the CVS store couldn’t refill my Losartan blood pressure medicine because it required re-authorization. I checked, and quickly saw that the refills had been less then previously.
I call the doctor’s office and I’m told that the insurance (I presume that’s Part D Medicare) now insists on more frequent monitoring, every six months, not every year. From a Medicare perspective, that encourages more doctor visits, more revenue for doctors, and more hits on the federal deficit for Medicare spending.
This seems to be driven by the opioid crisis, which I have nothing to do with. But “big government” has dragged me into it anyway.
There are some remote issues with some blood pressure meds. They can, in rare cases, lead to afib or cardiac arrests. Still, this is opening my own life, at least, to possible unnecessary disruption and interruption.